InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Cheng Sohanya Roshan. Officer active across 1 company, notably Karyopharm Therapeutics Inc.. In total, 19 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €101k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 14 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cheng Sohanya Roshan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
324 股@ US$9.500.0015% mcap16.4% 占其流量Common StockSEC:0001193125-26-226652:1
947 股0Common StockSEC:0001193125-26-226652:0
4,604 股@ US$9.409536.6% 占其流量Common StockSEC:0001865796-26-000003:0
32,415 股0Common StockSEC:0001193125-26-035687:0
43,650 股0Common StockSEC:0001193125-25-241468:0
945 股0Common StockSEC:0001193125-25-205042:0
3,445 股@ US$6.2932.4% 占其流量Common StockSEC:0000950170-25-034743:0
5,416 股0Common StockSEC:0000950170-25-032323:0
5,356 股@ US$0.72185.5% 占其流量Common StockSEC:0000950170-24-103998:0
21,840 股@ US$1.1736.9% 占其流量CommonSEC:0000950170-24-025189:0
198,959 股0Common StockSEC:0000950170-24-023285:0
14,167 股0Common StockSEC:0000950170-24-007621:0
7,415 股@ US$1.331314.3% 占其流量Common StockSEC:0001209191-23-048159:0
1,839 股@ US$2.356.3% 占其流量Common StockSEC:0001209191-23-036248:0
100,000 股0Common StockSEC:0001209191-23-014861:0
30,000 股0Common StockSEC:0001209191-22-048395:0
66 股@ US$5.3450.0002% mcap100.0% 占其流量Common StockSEC:0001209191-22-036812:0
84,000 股0Common StockSEC:0001209191-22-014622:0
7,500 股0Common StockSEC:0001209191-21-044423:0
19 条申报中的 19 条
About Cheng Sohanya Roshan
Cheng Sohanya Roshan is a declarant associated with Karyopharm Therapeutics Inc. in the role of EVP & Chief Commercial Officer. The record shows 19 filings in total, and across the recent filings tracked, the transactions are sales for EUR 100660, with a date range from 2021-07-01 to 2026-05-15; the most frequent transaction nature is Attribution.
